Experience
Eli Lilly and Company v. Sicor Pharmaceuticals, Inc.
Eli Lilly and Company
Sicor Pharmaceuticals, Inc.
Represented Eli Lilly in ANDA litigation to prevent generic competition for anti-cancer drug Gemzar®. One patent found valid after trial, recovery on second patent barred by Sun decision. Affirmed on appeal.
Eli Lilly and Company v. Sicor Pharmaceuticals, Inc., 1:06-cv-00238, S.D. Ind., Judges Barker, McVicker Lynch, Magnus-Stinson
